Table 1.

Profile of study respondents (n=57)

Characteristic	No. of patients (%)
Histologic subtype
Small cell	49 (86)
Large cell	8 (14)
Stage
I	36 (63)
II	13 (23)
III	2 (4)
IV	6 (11)
Country of residence
Australia	3 (5)
Canada	1 (2)
China (Hong Kong)	1 (2)
Ireland	1 (2)
New Zealand	1 (2)
Norway	2 (4)
United Kingdom	3 (5)
United States	45 (79)
United States region
South	14
West	15
Midwest	8
Northeast	8
Specialty of primary oncology provider
Gynecologic oncology	38 (67)
Medical oncology	9 (16)
Radiation oncology	3 (5)
More than 1 specialty	7 (12)